Cancer clinical trials in the region Auvergne-Rhône-Alpes

495 currently recruiting clinical trials
Region Auvergne-Rhône-Alpes
Phase 1 / Phase 2 Lymphoma #NCT06137144
Module 1 Cohorte 1
Required histologic types
Hodgkin lymphoma
Required number of previous lines of therapy
2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
3 recruiting sites
AstraZeneca
Phase 1 / Phase 2 Acute leukemia #NCT04811560
Phase 2
Required histologic types
Acute myeloid leukemia (AML)
Required central nervous system lesions
None Treated / Controled
Required genetic anomalies
KMT2A NPM1
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
11 recruiting sites
Janssen
Phase 1 / Phase 2 Acute leukemia #NCT04811560
Phase 1
Required central nervous system lesions
None Treated / Controled
Required genetic anomalies
Other mutation KMT2A NPM1 NUP214
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
11 recruiting sites
Janssen
Phase 1 / Phase 2 Lymphoma #NCT05475925
Escalade de dose (partie A) et Extension de dose (partie B) cohorte B2
Required histologic types
T cell lymphoma
Required histologic sub types
Peripheral T cell lymphoma Cutaneous T-cell lymphoma
Required disease stage
Disseminated (stage III and IV)
Required central nervous system lesions
None Treated / Controled
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
3 recruiting sites
Dren Bio
Phase 1 / Phase 2 Acute leukemia #NCT06356922
Required histologic types
Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML)
Required central nervous system lesions
None
Required renal function statuses
> 60 ml/min 50-60 ml/min
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
4 recruiting sites
Hôpital universitaire de Nantes
Phase 1 / Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST Thymus cancer Penile cancer and germ cell tumors #NCT05118789
Required disease stage
Locally Advanced Metastatic
Required genetic anomalies
ROS-1
Required number of previous lines of therapy for current stage of disease
1
4 recruiting sites
Nuvalent Inc.
Phase 1 / Phase 2 Sarcoma and GIST #NCT02275286 #2024-518199-30-00
Cohorte D
Required histologic types
Soft tissue sarcoma
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None 1
Required previous treatments at localized stage
Systemic Treatment-Naive Chemotherapy
Required soft tissue sarcoma locations
Retroperitoneum
Required sarcoma grades
Grade 2
Excluded previous treatments at localized stage
Surgery Radiotherapy
2 recruiting sites
Grupo Espanol de Investigacion en Sarcomas
Phase 1 / Phase 2 Sarcoma and GIST #NCT02275286 #2024-518199-30-00
Cohorte C
Required histologic types
Soft tissue sarcoma
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Required soft tissue sarcoma locations
Retroperitoneum
Required sarcoma grades
Grade 2 Grade 3
Excluded previous treatments at localized stage
Surgery Chemotherapy Radiotherapy
2 recruiting sites
Grupo Espanol de Investigacion en Sarcomas
Phase 1 / Phase 2 Breast cancer Prostate cancer #NCT06253130 #2023-509230-19
Required disease stage
Locally Advanced Metastatic Metastatic Castration-resistant
Required genetic anomalies
ATM BRCA 1/2 CHEK 1/2 PALB2 Other mutation
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Required previous treatments at localized stage
Chemotherapy
Required previous treatments at advanced or metastatic stage
Chemotherapy Hormone therapy
3 recruiting sites
Eikon Therapeutics
Phase 1 / Phase 2 Sarcoma and GIST #NCT02275286 #2024-518199-30-00
Cohorte D
Required histologic types
Soft tissue sarcoma
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None 1
Required previous treatments at localized stage
Systemic Treatment-Naive Chemotherapy
Required soft tissue sarcoma locations
Retroperitoneum
2 recruiting sites
Grupo Espanol de Investigacion en Sarcomas